Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021

SELL
$282.99 - $369.05 $1.21 Million - $1.57 Million
-4,262 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$259.0 - $414.71 $12.1 Million - $19.5 Million
-46,908 Reduced 91.67%
4,262 $1.48 Million
Q1 2021

May 12, 2021

BUY
$242.95 - $284.63 $3.83 Million - $4.49 Million
15,760 Added 44.51%
51,170 $14.3 Million
Q4 2020

Feb 10, 2021

SELL
$236.26 - $355.63 $14.7 Million - $22.1 Million
-62,150 Reduced 63.7%
35,410 $8.67 Million
Q3 2020

Nov 10, 2020

SELL
$264.77 - $305.71 $535,894 - $618,757
-2,024 Reduced 2.03%
97,560 $27.7 Million
Q2 2020

Aug 10, 2020

SELL
$258.66 - $342.55 $2.85 Million - $3.77 Million
-11,010 Reduced 9.96%
99,584 $26.6 Million
Q1 2020

May 13, 2020

BUY
$268.85 - $341.04 $147,329 - $186,889
548 Added 0.5%
110,594 $35 Million
Q4 2019

Feb 10, 2020

SELL
$220.06 - $304.07 $873,198 - $1.21 Million
-3,968 Reduced 3.48%
110,046 $32.7 Million
Q3 2019

Nov 07, 2019

BUY
$217.44 - $243.88 $119,157 - $133,646
548 Added 0.48%
114,014 $26.5 Million
Q2 2019

Aug 15, 2019

SELL
$219.29 - $241.72 $2.09 Million - $2.31 Million
-9,541 Reduced 7.76%
113,466 $26.5 Million
Q1 2019

May 10, 2019

BUY
$216.71 - $338.96 $7.77 Million - $12.2 Million
35,853 Added 41.14%
123,007 $29.1 Million
Q4 2018

Feb 12, 2019

SELL
$278.5 - $352.75 $12.2 Million - $15.4 Million
-43,636 Reduced 33.36%
87,154 $26.2 Million
Q3 2018

Nov 13, 2018

BUY
$293.51 - $383.83 $871,137 - $1.14 Million
2,968 Added 2.32%
130,790 $46.2 Million
Q2 2018

Aug 09, 2018

SELL
$257.52 - $306.91 $876,855 - $1.05 Million
-3,405 Reduced 2.59%
127,822 $37.1 Million
Q1 2018

May 03, 2018

SELL
$260.13 - $367.91 $332,966 - $470,924
-1,280 Reduced 0.97%
131,227 $35.9 Million
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $318,407 - $356,640
1,035 Added 0.79%
132,507 $46.1 Million
Q3 2017

Nov 15, 2017

BUY
$281.15 - $329.69 $37 Million - $43.3 Million
131,472
131,472 $41.2 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Argent Capital Management LLC Portfolio

Follow Argent Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argent Capital Management LLC with notifications on news.